GSK plc Revenue And Operating Income
GSK plc (GLAXF) reported Revenue And Operating Income of GBP 127.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Income Statement › Other Income
ifrs-full:RevenueAndOperatingIncome · last filed 2026-03-06
| Period end | Revenue And Operating Income | Revenue And Operating Income 12 month |
|---|---|---|
| 2025-12-31 | 127.00M GBP 20-F · filed 2026-03-06 | |
| 2024-12-31 | 176.00M GBP 20-F · filed 2026-03-06 | |
| 2023-12-31 | 192.00M GBP 20-F · filed 2025-03-03 | |
| 2022-12-31 | 85.00M GBP 20-F · filed 2024-03-05 | |
| 2021-12-31 | 29.00M GBP 20-F · filed 2023-03-10 | |
| 2020-12-31 | 33.00M GBP 20-F · filed 2022-03-08 | |
| 2019-12-31 | 72.00M GBP 20-F · filed 2021-03-12 | |
| 2019-01-01 | 72.00M GBP 20-F · filed 2020-03-06 | |
| 2018-12-31 | 66.00M GBP 20-F · filed 2020-03-06 | |
| 2018-01-01 | 66.00M GBP 20-F · filed 2019-03-15 |